Fresenius Medical Care AG (XTER:FME) Cyclically Adjusted Revenue per Share: €71.41 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:FME Fresenius Medical Care AG XTER:FME
74 GF Score
Price €42.40
GF Value €41.42
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Cyclically Adjusted Revenue per Share?

Fresenius Medical Care AG XTER:FME -1.26% 74 Cyclically Adjusted Revenue per Share is €71.41 as of Mar. 2026. GuruFocus rates XTER:FME with a GF Score™ of 74/100 and a GF Value™ of €41.42 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Fresenius Medical Care AG's adjusted revenue per share for the three months ended in Mar. 2026 was €16.756. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €71.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Fresenius Medical Care AG's average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Fresenius Medical Care AG was 10.00% per year. The lowest was 3.50% per year. And the median was 7.50% per year.

As of today (2026-07-15), Fresenius Medical Care AG's current stock price is €42.40. Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €71.41. Fresenius Medical Care AG's Cyclically Adjusted PS Ratio of today is 0.59.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius Medical Care AG was 2.41. The lowest was 0.43. And the median was 1.23.


Fresenius Medical Care AG  (XTER:FME) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius Medical Care AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=42.40/71.41
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius Medical Care AG was 2.41. The lowest was 0.43. And the median was 1.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Related Terms


Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.34 61.35 65.87 68.96 70.39

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.48 69.88 70.43 70.39 71.41

XTER:FME vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Cyclically Adjusted PS Ratio falls into.


XTER:FME
74GF Score
Fresenius Medical Care AG XTER:FME
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fresenius Medical Care AG's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=16.756/131.2583*131.2583
=16.756

Current CPI (Mar. 2026) = 131.2583.

Fresenius Medical Care AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 13.176 100.717 17.172
201609 13.765 101.017 17.886
201612 14.349 101.217 18.608
201703 14.758 101.417 19.100
201706 14.477 102.117 18.608
201709 14.143 102.717 18.073
201712 14.230 102.617 18.202
201803 12.973 102.917 16.545
201806 13.693 104.017 17.279
201809 13.239 104.718 16.594
201812 14.011 104.217 17.646
201903 13.476 104.217 16.973
201906 14.318 105.718 17.777
201909 14.660 106.018 18.150
201912 15.304 105.818 18.983
202003 15.057 105.718 18.695
202006 15.568 106.618 19.166
202009 15.061 105.818 18.682
202012 15.025 105.518 18.690
202103 14.369 107.518 17.542
202106 14.749 108.486 17.845
202109 15.151 109.435 18.172
202112 15.860 110.384 18.859
202203 15.519 113.968 17.873
202206 16.226 115.760 18.398
202209 17.369 118.818 19.188
202212 17.030 119.345 18.730
202303 16.033 122.402 17.193
202306 16.444 123.140 17.528
202309 16.824 124.195 17.781
202312 17.000 123.773 18.028
202403 16.102 125.038 16.903
202406 16.245 125.882 16.939
202409 16.223 126.198 16.874
202412 17.330 127.041 17.905
202503 16.637 127.779 17.090
202506 16.331 128.412 16.693
202509 16.723 129.255 16.982
202512 17.735 129.361 17.995
202603 16.756 131.258 16.756

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €71.41 mean?
Fresenius Medical Care AG (XTER:FME) has a Cyclically Adjusted Revenue per Share of €71.41 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share too high?
Fresenius Medical Care AG's current Cyclically Adjusted Revenue per Share is €71.41. Overall, Fresenius Medical Care AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share of €71.41 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Cyclically Adjusted Revenue per Share is €71.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (XTER:FME) is currently considered Fairly Valued. The stock's GF Value™ is €41.42, compared to a current price of €42.40 — trading 2.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €71.41. Fresenius Medical Care AG's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Fresenius Medical Care AG (XTER:FME), the current Cyclically Adjusted Revenue per Share is €71.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (XTER:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued. The current stock price of €42.40 is trading 2.4% above its estimated GF Value™ of €41.42. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for XTER:FME:

  • Cyclically Adjusted Revenue per Share: €71.41
  • GF Value™: €41.42 vs. price of €42.40 (2.4% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the XTER:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
74GF Score

Get the complete analysis for XTER:FME

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.40
Price
€41.42
GF Value